JP2013527173A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527173A5 JP2013527173A5 JP2013509262A JP2013509262A JP2013527173A5 JP 2013527173 A5 JP2013527173 A5 JP 2013527173A5 JP 2013509262 A JP2013509262 A JP 2013509262A JP 2013509262 A JP2013509262 A JP 2013509262A JP 2013527173 A5 JP2013527173 A5 JP 2013527173A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyridinyl
- oxo
- dihydro
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 where said ring Chemical group 0.000 claims 82
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 43
- 125000001072 heteroaryl group Chemical group 0.000 claims 36
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 33
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 30
- 125000003118 aryl group Chemical group 0.000 claims 27
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 26
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 125000004093 cyano group Chemical group *C#N 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 21
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 19
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 16
- 229910052757 nitrogen Inorganic materials 0.000 claims 16
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 claims 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 14
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 229910052760 oxygen Inorganic materials 0.000 claims 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 10
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 10
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 150000001602 bicycloalkyls Chemical group 0.000 claims 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 6
- 125000003282 alkyl amino group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 229910052717 sulfur Chemical group 0.000 claims 5
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229910002091 carbon monoxide Inorganic materials 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims 4
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims 2
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 claims 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 2
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 claims 2
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- SNICLKHAPMIQAK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCN(C)CC1 SNICLKHAPMIQAK-UHFFFAOYSA-N 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims 2
- 150000003536 tetrazoles Chemical class 0.000 claims 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims 2
- 229930192474 thiophene Natural products 0.000 claims 2
- 150000003852 triazoles Chemical class 0.000 claims 2
- JCWWOICHWDKSPS-UHFFFAOYSA-N 1,6-ditert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(C(C)(C)C)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O JCWWOICHWDKSPS-UHFFFAOYSA-N 0.000 claims 1
- CKQCYGJHRBQQHV-UHFFFAOYSA-N 1-(2-aminoethyl)-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(C)=CC(C)=C1CNC(=O)C1=CC(C2CC2)=NC2=C1C=NN2CCN CKQCYGJHRBQQHV-UHFFFAOYSA-N 0.000 claims 1
- ZPVOFDSZWZKZJS-UHFFFAOYSA-N 1-amino-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(C)=CC(C)=C1CNC(=O)C1=CC(C2CC2)=NC2=C1C=NN2N ZPVOFDSZWZKZJS-UHFFFAOYSA-N 0.000 claims 1
- FTRNTBOWPSRAEH-UHFFFAOYSA-N 1-benzyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C=NN(CC=3C=CC=CC=3)C2=NC(C)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O FTRNTBOWPSRAEH-UHFFFAOYSA-N 0.000 claims 1
- IIDGHJNVOYHFLT-UHFFFAOYSA-N 1-cyclobutyl-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C12=NC(C3CC3)=CC(C(=O)NCC=3C(NC(C)=CC=3C)=O)=C2C(C)=NN1C1CCC1 IIDGHJNVOYHFLT-UHFFFAOYSA-N 0.000 claims 1
- ZVWGPMUZNXVNEB-UHFFFAOYSA-N 1-cyclohexyl-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C12=NC(C3CC3)=CC(C(=O)NCC=3C(NC(C)=CC=3C)=O)=C2C(C)=NN1C1CCCCC1 ZVWGPMUZNXVNEB-UHFFFAOYSA-N 0.000 claims 1
- BCXVOWWRYJQHNM-UHFFFAOYSA-N 1-cyclopentyl-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C12=NC(C3CC3)=CC(C(=O)NCC=3C(NC(C)=CC=3C)=O)=C2C(C)=NN1C1CCCC1 BCXVOWWRYJQHNM-UHFFFAOYSA-N 0.000 claims 1
- VKSDJJINVLWPPN-UHFFFAOYSA-N 1-tert-butyl-6-chloro-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(Cl)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O VKSDJJINVLWPPN-UHFFFAOYSA-N 0.000 claims 1
- VUJVCWWIQRDSNQ-UHFFFAOYSA-N 1-tert-butyl-6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(C2CC2)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O VUJVCWWIQRDSNQ-UHFFFAOYSA-N 0.000 claims 1
- GBNAZZHFAWCZDP-UHFFFAOYSA-N 1-tert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-(2-oxo-1,3-dihydrobenzimidazol-5-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(C=2C=C3NC(=O)NC3=CC=2)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O GBNAZZHFAWCZDP-UHFFFAOYSA-N 0.000 claims 1
- KFGLSNDZHPVZLB-UHFFFAOYSA-N 1-tert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-(6-morpholin-4-ylpyridin-3-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(C=2C=NC(=CC=2)N2CCOCC2)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O KFGLSNDZHPVZLB-UHFFFAOYSA-N 0.000 claims 1
- MNFXCZXHQVNDKD-UHFFFAOYSA-N 1-tert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C=2N=C3N(N=C(C)C3=C(C(=O)NCC=3C(NC(C)=CC=3C)=O)C=2)C(C)(C)C)C=N1 MNFXCZXHQVNDKD-UHFFFAOYSA-N 0.000 claims 1
- ZOZATYKUQBINTC-UHFFFAOYSA-N 1-tert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-pyridin-3-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C(C)=NN(C(C)(C)C)C2=NC(C=2C=NC=CC=2)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O ZOZATYKUQBINTC-UHFFFAOYSA-N 0.000 claims 1
- WFAPQHAQUNZYKQ-UHFFFAOYSA-N 1-tert-butyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(4-methoxyphenyl)-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C(C)=NN2C(C)(C)C)C2=N1 WFAPQHAQUNZYKQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- ZYGCNKBZFDOZPV-UHFFFAOYSA-N 6-(2,1,3-benzoxadiazol-5-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C2=CC3=NON=C3C=C2)N=C2N(C(C)C)N=C(C)C2=C1C(=O)NCC1=C(C)C=C(C)NC1=O ZYGCNKBZFDOZPV-UHFFFAOYSA-N 0.000 claims 1
- ROUZJNZVOLGBLI-UHFFFAOYSA-N 6-(2-aminopyridin-4-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=NC(N)=C1 ROUZJNZVOLGBLI-UHFFFAOYSA-N 0.000 claims 1
- JNXHLGFBCMVYNR-UHFFFAOYSA-N 6-(2-aminopyrimidin-5-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CN=C(N)N=C1 JNXHLGFBCMVYNR-UHFFFAOYSA-N 0.000 claims 1
- BBSASWROZCPDRJ-UHFFFAOYSA-N 6-(2h-benzotriazol-5-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3N=NNC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O BBSASWROZCPDRJ-UHFFFAOYSA-N 0.000 claims 1
- PYZYAPPUGKUPEE-UHFFFAOYSA-N 6-(3-acetamidophenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC(NC(C)=O)=C1 PYZYAPPUGKUPEE-UHFFFAOYSA-N 0.000 claims 1
- CYKQSUGLXKUFHX-UHFFFAOYSA-N 6-(3-aminophenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC(N)=C1 CYKQSUGLXKUFHX-UHFFFAOYSA-N 0.000 claims 1
- GQCKGKFHRBAKCN-UHFFFAOYSA-N 6-(4-acetamidophenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(NC(C)=O)C=C1 GQCKGKFHRBAKCN-UHFFFAOYSA-N 0.000 claims 1
- SPDITUWEEYOCJY-UHFFFAOYSA-N 6-(4-acetamidophenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(NC(C)=O)C=C1 SPDITUWEEYOCJY-UHFFFAOYSA-N 0.000 claims 1
- NCTMOSCJBLHHAG-UHFFFAOYSA-N 6-(4-aminophenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(N)C=C1 NCTMOSCJBLHHAG-UHFFFAOYSA-N 0.000 claims 1
- KWPKXQFYRMVTLS-UHFFFAOYSA-N 6-(4-carbamoylanilino)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NC1=CC=C(C(N)=O)C=C1 KWPKXQFYRMVTLS-UHFFFAOYSA-N 0.000 claims 1
- QZGYRKOMVWBKSE-UHFFFAOYSA-N 6-(4-carbamoylphenyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(C(N)=O)C=C1 QZGYRKOMVWBKSE-UHFFFAOYSA-N 0.000 claims 1
- QMMFSKNFVSSDEK-UHFFFAOYSA-N 6-(6-aminopyridin-3-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(N)N=C1 QMMFSKNFVSSDEK-UHFFFAOYSA-N 0.000 claims 1
- OXYLZYCQFHCRDZ-UHFFFAOYSA-N 6-(benzylamino)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NCC1=CC=CC=C1 OXYLZYCQFHCRDZ-UHFFFAOYSA-N 0.000 claims 1
- PYPWLVFEJOOVDR-UHFFFAOYSA-N 6-[2-(dimethylamino)ethylamino]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(NCCN(C)C)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O PYPWLVFEJOOVDR-UHFFFAOYSA-N 0.000 claims 1
- ROLJNRNHZVGSDA-UHFFFAOYSA-N 6-[5-(benzenesulfonamido)pyridin-3-yl]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=1)=CN=CC=1NS(=O)(=O)C1=CC=CC=C1 ROLJNRNHZVGSDA-UHFFFAOYSA-N 0.000 claims 1
- OPKVDCHRFVMHAG-UHFFFAOYSA-N 6-[5-(cyclopropylsulfonylamino)-6-methoxypyridin-3-yl]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound COC1=NC=C(C=2N=C3N(C(C)C)N=CC3=C(C(=O)NCC=3C(NC(C)=CC=3C)=O)C=2)C=C1NS(=O)(=O)C1CC1 OPKVDCHRFVMHAG-UHFFFAOYSA-N 0.000 claims 1
- VZGZROHQXCXVNG-UHFFFAOYSA-N 6-[6-(dimethylamino)pyridin-3-yl]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(N(C)C)N=C1 VZGZROHQXCXVNG-UHFFFAOYSA-N 0.000 claims 1
- SEKDNVJKSGMKBR-UHFFFAOYSA-N 6-amino-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(N)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O SEKDNVJKSGMKBR-UHFFFAOYSA-N 0.000 claims 1
- ZJBQVJXGTZEWCX-UHFFFAOYSA-N 6-anilino-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NC1=CC=CC=C1 ZJBQVJXGTZEWCX-UHFFFAOYSA-N 0.000 claims 1
- FABMZTHRDOHPDN-UHFFFAOYSA-N 6-chloro-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(Cl)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O FABMZTHRDOHPDN-UHFFFAOYSA-N 0.000 claims 1
- SWHWPZPVKCRCLG-UHFFFAOYSA-N 6-cyclopropyl-1-(1-cyclopropylethyl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C(C)C2=C(C(=O)NCC=3C(NC(C)=CC=3C)=O)C=C(C3CC3)N=C2N1C(C)C1CC1 SWHWPZPVKCRCLG-UHFFFAOYSA-N 0.000 claims 1
- RQNMLYXYHKMXAV-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-[2-(methanesulfonamido)ethyl]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(C)=CC(C)=C1CNC(=O)C1=CC(C2CC2)=NC2=C1C=NN2CCNS(C)(=O)=O RQNMLYXYHKMXAV-UHFFFAOYSA-N 0.000 claims 1
- NAGLYMIXBUFMJR-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(CC)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1CC1 NAGLYMIXBUFMJR-UHFFFAOYSA-N 0.000 claims 1
- CKWGNYPWTNPJTL-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(CCC)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1CC1 CKWGNYPWTNPJTL-UHFFFAOYSA-N 0.000 claims 1
- ONAZPLZAUCSZBY-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(C)=CC(C)=C1CNC(=O)C1=CC(C2CC2)=NC2=C1C=NN2C1=CC=NC=C1 ONAZPLZAUCSZBY-UHFFFAOYSA-N 0.000 claims 1
- PKSJPYKWNYLLFG-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1CN(C)CCC1N1C2=NC(C3CC3)=CC(C(=O)NCC=3C(NC(C)=CC=3C)=O)=C2C(C)=N1 PKSJPYKWNYLLFG-UHFFFAOYSA-N 0.000 claims 1
- CDIJNQNSRQUHHH-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-(oxan-4-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C12=NC(C3CC3)=CC(C(=O)NCC=3C(NC(C)=CC=3C)=O)=C2C(C)=NN1C1CCOCC1 CDIJNQNSRQUHHH-UHFFFAOYSA-N 0.000 claims 1
- IYHWHTORRRTBJP-UHFFFAOYSA-N 6-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1CC1 IYHWHTORRRTBJP-UHFFFAOYSA-N 0.000 claims 1
- AWMFEVJSBRGMKX-UHFFFAOYSA-N 6-cyclopropyl-n-[(4-methyl-2-oxo-6-propyl-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(CCC)=CC(C)=C1CNC(=O)C1=CC(C2CC2)=NC2=C1C=NN2C(C)C AWMFEVJSBRGMKX-UHFFFAOYSA-N 0.000 claims 1
- GDDSMOUZBSWFPX-UHFFFAOYSA-N 6-cyclopropyl-n-[(6-methyl-2-oxo-4-phenyl-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C=2C=CC=CC=2)=O)C=C1C1CC1 GDDSMOUZBSWFPX-UHFFFAOYSA-N 0.000 claims 1
- YBGKRLSRBCWQEQ-UHFFFAOYSA-N 6-cyclopropyl-n-[(6-methyl-2-oxo-4-propan-2-yl-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3C=NN(C=3N=C(C=2)C2CC2)C(C)C)=C1C(C)C YBGKRLSRBCWQEQ-UHFFFAOYSA-N 0.000 claims 1
- FSDXIBKXOHYNOA-UHFFFAOYSA-N 6-cyclopropyl-n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3C=NN(C=3N=C(C=2)C2CC2)C(C)C)=C1CCC FSDXIBKXOHYNOA-UHFFFAOYSA-N 0.000 claims 1
- DHKHLSCPKJCJNP-UHFFFAOYSA-N 6-cyclopropyl-n-[[6-methyl-2-oxo-4-(trifluoromethyl)-1h-pyridin-3-yl]methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C(F)(F)F)=O)C=C1C1CC1 DHKHLSCPKJCJNP-UHFFFAOYSA-N 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000012609 Cowden disease Diseases 0.000 claims 1
- 201000002847 Cowden syndrome Diseases 0.000 claims 1
- 206010014967 Ependymoma Diseases 0.000 claims 1
- 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
- 208000007569 Giant Cell Tumors Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 claims 1
- 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000008383 Wilms tumor Diseases 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 201000004653 inflammatory breast carcinoma Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- RVPHJHONMNAGSK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1,6-di(propan-2-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C=NN(C(C)C)C2=NC(C(C)C)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O RVPHJHONMNAGSK-UHFFFAOYSA-N 0.000 claims 1
- CPVQOGUURKEJJM-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-(1h-pyrazol-4-yl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C=1C=NNC=1 CPVQOGUURKEJJM-UHFFFAOYSA-N 0.000 claims 1
- LVQZSFQDGDBHJW-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-(2-pyridin-4-ylethynyl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C#CC1=CC=NC=C1 LVQZSFQDGDBHJW-UHFFFAOYSA-N 0.000 claims 1
- IWIDAPBNWDDLAR-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-(4-sulfamoylphenyl)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(S(N)(=O)=O)C=C1 IWIDAPBNWDDLAR-UHFFFAOYSA-N 0.000 claims 1
- MMDJLTWESKNNRE-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-(prop-2-enylamino)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(NCC=C)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O MMDJLTWESKNNRE-UHFFFAOYSA-N 0.000 claims 1
- LYTGPDCLJDARQE-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-(pyridin-4-ylmethylamino)pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NCC1=CC=NC=C1 LYTGPDCLJDARQE-UHFFFAOYSA-N 0.000 claims 1
- MPJYQHLASWTWKG-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-[2-(pyridin-2-ylamino)ethylamino]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NCCNC1=CC=CC=N1 MPJYQHLASWTWKG-UHFFFAOYSA-N 0.000 claims 1
- HFENIZQGGJKRRU-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-[4-(1h-pyrazol-4-yl)phenyl]pyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=C1)=CC=C1C=1C=NNC=1 HFENIZQGGJKRRU-UHFFFAOYSA-N 0.000 claims 1
- GQEAQQLZXOTRPN-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CN=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O GQEAQQLZXOTRPN-UHFFFAOYSA-N 0.000 claims 1
- SHDVMUJMBBILPO-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=NC=C1 SHDVMUJMBBILPO-UHFFFAOYSA-N 0.000 claims 1
- MAMZJJPZEPIRKX-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-(2-oxo-1,3-dihydrobenzimidazol-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3NC(=O)NC3=CC=2)N=C2N(C(C)C)N=C(C)C2=C1C(=O)NCC1=C(C)C=C(C)NC1=O MAMZJJPZEPIRKX-UHFFFAOYSA-N 0.000 claims 1
- HHFDOLJYRZAQEN-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-(6-morpholin-4-ylpyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCOCC1 HHFDOLJYRZAQEN-UHFFFAOYSA-N 0.000 claims 1
- UVODPARGBXNUQU-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-[4-(methylsulfamoyl)phenyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C(C)=NN2C(C)C)C2=N1 UVODPARGBXNUQU-UHFFFAOYSA-N 0.000 claims 1
- DYBCKEUECIXCMR-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-methyl-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCN(C)CC1 DYBCKEUECIXCMR-UHFFFAOYSA-N 0.000 claims 1
- HXLVZOZISHVQAP-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(1h-indazol-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3C=NNC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O HXLVZOZISHVQAP-UHFFFAOYSA-N 0.000 claims 1
- DPOKPPDUEUFLKK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(1h-indazol-6-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3NN=CC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O DPOKPPDUEUFLKK-UHFFFAOYSA-N 0.000 claims 1
- SWERKTWCPWPYOB-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2,4-dioxo-1h-pyrimidin-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CNC(=O)NC1=O SWERKTWCPWPYOB-UHFFFAOYSA-N 0.000 claims 1
- CRYXKQPGUZMKLK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-hydroxyethylamino)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(NCCO)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O CRYXKQPGUZMKLK-UHFFFAOYSA-N 0.000 claims 1
- FENLBPIFXYKGLZ-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-methoxypyridin-4-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=NC(OC)=CC(C=2N=C3N(C(C)C)N=CC3=C(C(=O)NCC=3C(NC(C)=CC=3C)=O)C=2)=C1 FENLBPIFXYKGLZ-UHFFFAOYSA-N 0.000 claims 1
- LXJKHNJMAHAASA-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-methylphenyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC=C1C LXJKHNJMAHAASA-UHFFFAOYSA-N 0.000 claims 1
- AVQKYORNLOKWBI-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-morpholin-4-ylpyridin-4-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=1)=CC=NC=1N1CCOCC1 AVQKYORNLOKWBI-UHFFFAOYSA-N 0.000 claims 1
- DEHLJNLCDLWSGP-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-nitrophenyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC=C1[N+]([O-])=O DEHLJNLCDLWSGP-UHFFFAOYSA-N 0.000 claims 1
- DHDAGJRZBJHQQW-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-oxo-1,3-dihydrobenzimidazol-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3NC(=O)NC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O DHDAGJRZBJHQQW-UHFFFAOYSA-N 0.000 claims 1
- KXXLCLVJGUVBTJ-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-oxo-1,3-dihydroindol-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3CC(=O)NC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O KXXLCLVJGUVBTJ-UHFFFAOYSA-N 0.000 claims 1
- VJRHUHGJWWANDO-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-oxo-1,3-dihydroindol-6-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3NC(=O)CC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O VJRHUHGJWWANDO-UHFFFAOYSA-N 0.000 claims 1
- YWNPYDHFOXXNNH-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-phenylethyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1CCC1=CC=CC=C1 YWNPYDHFOXXNNH-UHFFFAOYSA-N 0.000 claims 1
- WCUROQOMQQPYKI-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(2-phenylethynyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C#CC1=CC=CC=C1 WCUROQOMQQPYKI-UHFFFAOYSA-N 0.000 claims 1
- FSUVZKXRKBJLHO-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(3-hydroxy-3-methylbut-1-ynyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C#CC(C)(C)O)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O FSUVZKXRKBJLHO-UHFFFAOYSA-N 0.000 claims 1
- ZFTBTZYCUSUGSY-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(3-methyl-2h-indazol-5-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3C(C)=NNC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O ZFTBTZYCUSUGSY-UHFFFAOYSA-N 0.000 claims 1
- YBAJUXLZNKTGDL-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(4-fluorophenyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(F)C=C1 YBAJUXLZNKTGDL-UHFFFAOYSA-N 0.000 claims 1
- VQFJTVSOZHCIFN-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(4-methoxyphenyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 VQFJTVSOZHCIFN-UHFFFAOYSA-N 0.000 claims 1
- ATORHKLYJPRWNI-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(4-methylsulfonylphenyl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(S(C)(=O)=O)C=C1 ATORHKLYJPRWNI-UHFFFAOYSA-N 0.000 claims 1
- KFMVMEOFGDXIJR-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(5-methoxypyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound COC1=CN=CC(C=2N=C3N(C(C)C)N=CC3=C(C(=O)NCC=3C(NC(C)=CC=3C)=O)C=2)=C1 KFMVMEOFGDXIJR-UHFFFAOYSA-N 0.000 claims 1
- KMQGNFBUFRVFNI-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(5-methylsulfonylpyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CN=CC(S(C)(=O)=O)=C1 KMQGNFBUFRVFNI-UHFFFAOYSA-N 0.000 claims 1
- STTDFESLIVVLKE-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(6-methoxypyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=NC(OC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 STTDFESLIVVLKE-UHFFFAOYSA-N 0.000 claims 1
- OBASFAPNSSLYMR-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(6-morpholin-4-ylpyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCOCC1 OBASFAPNSSLYMR-UHFFFAOYSA-N 0.000 claims 1
- JRHSMAGHHVRSNA-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(7-oxo-6,8-dihydro-5h-1,8-naphthyridin-3-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C=2C=C3CCC(=O)N=C3NC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O JRHSMAGHHVRSNA-UHFFFAOYSA-N 0.000 claims 1
- TVEDDGSQQZGNAT-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(ethylamino)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C=12C=NN(C(C)C)C2=NC(NCC)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O TVEDDGSQQZGNAT-UHFFFAOYSA-N 0.000 claims 1
- FJMKUHGWRIGUAK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(oxan-4-ylamino)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NC1CCOCC1 FJMKUHGWRIGUAK-UHFFFAOYSA-N 0.000 claims 1
- KHDOEYMZHHRWEA-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-(piperidin-4-ylamino)-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1NC1CCNCC1 KHDOEYMZHHRWEA-UHFFFAOYSA-N 0.000 claims 1
- CZQGOIXSJFKZPT-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(NC=2C=C3NC(=O)NC3=CC=2)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O CZQGOIXSJFKZPT-UHFFFAOYSA-N 0.000 claims 1
- SXFSERCDFHFHJK-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[4-(dimethylsulfamoyl)phenyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(S(=O)(=O)N(C)C)C=C1 SXFSERCDFHFHJK-UHFFFAOYSA-N 0.000 claims 1
- YJGGPWSQBLSTLJ-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[4-(dimethylsulfamoyl)phenyl]-3-methyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(S(=O)(=O)N(C)C)C=C1 YJGGPWSQBLSTLJ-UHFFFAOYSA-N 0.000 claims 1
- AKBZTJSWWZBIFH-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[4-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(NS(C)(=O)=O)C=C1 AKBZTJSWWZBIFH-UHFFFAOYSA-N 0.000 claims 1
- KLLPIDYLSWTUIN-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[4-(methylcarbamoyl)phenyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 KLLPIDYLSWTUIN-UHFFFAOYSA-N 0.000 claims 1
- MDSJORDMNXSQSC-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[4-(methylsulfamoyl)phenyl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 MDSJORDMNXSQSC-UHFFFAOYSA-N 0.000 claims 1
- GBVZGIPBVWHTPF-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[6-(methylcarbamoyl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 GBVZGIPBVWHTPF-UHFFFAOYSA-N 0.000 claims 1
- FWXFWFSWSFPYIC-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-[6-(methylsulfamoyl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=NC(S(=O)(=O)NC)=CC=C1C1=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C=NN2C(C)C)C2=N1 FWXFWFSWSFPYIC-UHFFFAOYSA-N 0.000 claims 1
- RENWHTRYJDRPJJ-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-methyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C)N=C2N(C(C)C)N=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O RENWHTRYJDRPJJ-UHFFFAOYSA-N 0.000 claims 1
- ZZVBQHITBBGRCU-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-6-phenyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC=C1 ZZVBQHITBBGRCU-UHFFFAOYSA-N 0.000 claims 1
- BNUXDHYJYYPKDG-UHFFFAOYSA-N n-[(4-cyclohexyl-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C2CCCCC2)=O)C=C1C1=CC=NC=C1 BNUXDHYJYYPKDG-UHFFFAOYSA-N 0.000 claims 1
- OZPJVSPZDPAKRN-UHFFFAOYSA-N n-[(4-cyclohexyl-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-6-cyclopropyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C2CCCCC2)=O)C=C1C1CC1 OZPJVSPZDPAKRN-UHFFFAOYSA-N 0.000 claims 1
- OTXZCSZGICIBRE-UHFFFAOYSA-N n-[(4-cyclopropyl-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C2CC2)=O)C=C1C1=CC=NC=C1 OTXZCSZGICIBRE-UHFFFAOYSA-N 0.000 claims 1
- MMOQOQZQWHKDKV-UHFFFAOYSA-N n-[(4-methyl-2-oxo-6-propyl-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(CCC)=CC(C)=C1CNC(=O)C1=CC(C=2C=CN=CC=2)=NC2=C1C=NN2C(C)C MMOQOQZQWHKDKV-UHFFFAOYSA-N 0.000 claims 1
- LGVTYHNKQRPTBZ-UHFFFAOYSA-N n-[(5-fluoro-4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=C(F)C=2C)=O)C=C1C1=CC=NC=C1 LGVTYHNKQRPTBZ-UHFFFAOYSA-N 0.000 claims 1
- PETSJQBBHVYOOQ-UHFFFAOYSA-N n-[(6-ethyl-4-methyl-2-oxo-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound O=C1NC(CC)=CC(C)=C1CNC(=O)C1=CC(C=2C=CN=CC=2)=NC2=C1C=NN2C(C)C PETSJQBBHVYOOQ-UHFFFAOYSA-N 0.000 claims 1
- DCBXUYVKNBIIEC-UHFFFAOYSA-N n-[(6-methyl-2-oxo-4-phenyl-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound N1=C2N(C(C)C)N=CC2=C(C(=O)NCC=2C(NC(C)=CC=2C=2C=CC=CC=2)=O)C=C1C1=CC=NC=C1 DCBXUYVKNBIIEC-UHFFFAOYSA-N 0.000 claims 1
- UHUSXQZYBIFRSI-UHFFFAOYSA-N n-[(6-methyl-2-oxo-4-propan-2-yl-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3C=NN(C=3N=C(C=2)C=2C=CN=CC=2)C(C)C)=C1C(C)C UHUSXQZYBIFRSI-UHFFFAOYSA-N 0.000 claims 1
- DJCPQWZBLRFOMD-UHFFFAOYSA-N n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-pyridin-4-ylpyrazolo[3,4-b]pyridine-4-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3C=NN(C=3N=C(C=2)C=2C=CN=CC=2)C(C)C)=C1CCC DJCPQWZBLRFOMD-UHFFFAOYSA-N 0.000 claims 1
- 201000008026 nephroblastoma Diseases 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 0 CC(*=C)(C=C1)C=CC2=C1NNN2 Chemical compound CC(*=C)(C=C1)C=CC2=C1NNN2 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33231410P | 2010-05-07 | 2010-05-07 | |
| US61/332,314 | 2010-05-07 | ||
| PCT/US2011/035344 WO2012005805A1 (en) | 2010-05-07 | 2011-05-05 | Azaindazoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527173A JP2013527173A (ja) | 2013-06-27 |
| JP2013527173A5 true JP2013527173A5 (https=) | 2014-06-26 |
| JP5889875B2 JP5889875B2 (ja) | 2016-03-22 |
Family
ID=45441481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509262A Expired - Fee Related JP5889875B2 (ja) | 2010-05-07 | 2011-05-05 | アザインダゾール |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8637509B2 (https=) |
| EP (1) | EP2566479B1 (https=) |
| JP (1) | JP5889875B2 (https=) |
| ES (1) | ES2528269T3 (https=) |
| WO (1) | WO2012005805A1 (https=) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2094836B1 (en) | 2006-11-15 | 2016-06-08 | Massachusetts Eye & Ear Infirmary | Generation of inner ear cells |
| UA110112C2 (uk) | 2010-05-07 | 2015-11-25 | Глаксосмітклайн Ллс | Індоли |
| US8846935B2 (en) | 2010-05-07 | 2014-09-30 | Glaxosmithkline Llc | Indazoles |
| US20130102477A1 (en) | 2010-06-23 | 2013-04-25 | Ryan D. Morin | Biomarkers for non-hodgkin lymphomas and uses thereof |
| US9175331B2 (en) | 2010-09-10 | 2015-11-03 | Epizyme, Inc. | Inhibitors of human EZH2, and methods of use thereof |
| BR112013005806B1 (pt) | 2010-09-10 | 2022-05-10 | Epizyme, Inc | Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2 |
| ES2607064T3 (es) | 2010-12-01 | 2017-03-29 | Glaxosmithkline Llc | Indoles |
| ES2951688T3 (es) | 2011-02-28 | 2023-10-24 | Epizyme Inc | Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos |
| AU2013203641B2 (en) * | 2011-04-13 | 2014-08-21 | Epizyme, Inc. | Aryl-or heteroaryl-substituted benzene compounds |
| JO3363B1 (ar) | 2011-04-13 | 2019-03-13 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
| TWI598336B (zh) | 2011-04-13 | 2017-09-11 | 雅酶股份有限公司 | 經取代之苯化合物 |
| EP2755962B1 (en) * | 2011-09-13 | 2017-03-01 | Glaxosmithkline LLC | Azaindazoles |
| BR112014010803A2 (pt) | 2011-11-04 | 2017-04-25 | Glaxosmithkline Intellectual Property (No 2) Ltd | método de tratamento |
| EP2780013A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| EP2780014A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| NZ628762A (en) | 2012-02-10 | 2016-07-29 | Constellation Pharmaceuticals Inc | Modulators of methyl modifying enzymes, compositions and uses thereof |
| EP3536314A1 (en) | 2012-03-12 | 2019-09-11 | Epizyme, Inc. | Inhibitors of human ezh2, and methods of use thereof |
| EP2828250B1 (en) | 2012-03-19 | 2021-03-10 | Imperial College Innovations Limited | Quinazoline compounds and their use in therapy |
| PT3184523T (pt) | 2012-04-13 | 2019-09-26 | Eisai R&D Man Co Ltd | Bromidrato de n-((4,6-dimetil-2-oxo-l,2-di-hidropiridin- 3-il)metil)-5-(etil(tetra-hidro-2h-piran-4-il)amino)-4- metil-4¿-(morfolinometil)-[l,1¿-bofenil]-3-carboxamida para utilização no tratamento de uma doença proliferativa celular do sistema hematológico |
| WO2013173441A2 (en) * | 2012-05-16 | 2013-11-21 | Glaxosmithkline Llc | Enhancer of zeste homolog 2 inhibitors |
| CA2883896C (en) | 2012-09-07 | 2023-03-07 | Massachusetts Eye & Ear Infirmary | Treating hearing loss |
| JP6254169B2 (ja) * | 2012-09-28 | 2017-12-27 | ファイザー・インク | ベンズアミドおよびヘテロベンズアミド化合物 |
| MX2015004721A (es) | 2012-10-15 | 2016-01-25 | Epizyme Inc | Compuestos de benceno sustituidos. |
| KR20230156450A (ko) | 2012-10-15 | 2023-11-14 | 에피자임, 인코포레이티드 | 암을 치료하는 방법 |
| CA2894222A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | 1,4-pyridone bicyclic heteroaryl compounds |
| UA111305C2 (uk) | 2012-12-21 | 2016-04-11 | Пфайзер Інк. | Конденсовані лактами арилу та гетероарилу |
| WO2014153172A1 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| KR20150127216A (ko) | 2013-03-14 | 2015-11-16 | 제넨테크, 인크. | 암의 치료 및 암 약물 내성의 예방 방법 |
| EP2970136A1 (en) | 2013-03-14 | 2016-01-20 | Epizyme, Inc. | Arginine methyl transferase inhibtors and uses thereof |
| CA2903264A1 (en) | 2013-03-14 | 2014-11-06 | Epizyme, Inc. | Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof |
| EP3363434A1 (en) | 2013-03-14 | 2018-08-22 | Epizyme Inc | Arginine methyltransferase inhibitors and uses thereof |
| US9765035B2 (en) | 2013-03-14 | 2017-09-19 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9023883B2 (en) | 2013-03-14 | 2015-05-05 | Epizyme, Inc. | PRMT1 inhibitors and uses thereof |
| EP2970134B1 (en) | 2013-03-14 | 2018-02-28 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| PL2970132T3 (pl) | 2013-03-14 | 2021-04-06 | Epizyme, Inc. | Inhibitory metylotransferazy argininy i ich zastosowania |
| US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9045455B2 (en) | 2013-03-14 | 2015-06-02 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2014151142A1 (en) | 2013-03-15 | 2014-09-25 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| EP2991980B1 (en) * | 2013-04-30 | 2019-01-02 | Glaxosmithkline Intellectual Property (No. 2) Limited | Enhancer of zeste homolog 2 inhibitors |
| KR20160030221A (ko) | 2013-07-10 | 2016-03-16 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 제스트 인핸서 상동체 2 억제제 |
| WO2015010078A2 (en) * | 2013-07-19 | 2015-01-22 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
| EP3033334A1 (en) | 2013-08-15 | 2016-06-22 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| MA38949A1 (fr) | 2013-10-16 | 2017-07-31 | Eisai R&D Man Co Ltd | Forme saline d'hydrochlorure pour inhibition d'ezh2 |
| WO2015168149A2 (en) | 2014-04-28 | 2015-11-05 | Massachusetts Eye & Ear Infirmary | Sensorineural hair cell differentiation |
| CN105017221B (zh) * | 2014-04-30 | 2019-05-28 | 中国医学科学院药物研究所 | 苯并咪唑衍生物及其制法和药物组合物与用途 |
| EP3157915B1 (en) | 2014-06-17 | 2019-02-27 | Pfizer Inc | Substituted dihydroisoquinolinone compounds |
| WO2016022776A2 (en) | 2014-08-06 | 2016-02-11 | Massachusetts Eye And Ear Infirmary | Increasing atoh1 life to drive sensorineural hair cell differentiantion |
| EP3885343A1 (en) | 2014-11-06 | 2021-09-29 | Dana-Farber Cancer Institute, Inc. | Indole compounds as ezh2 inhibitors and uses thereof |
| EP3215160A4 (en) * | 2014-11-06 | 2018-08-08 | Dana-Farber Cancer Institute, Inc. | Use of compositions modulating chromatin structure for graft versus host disease (gvhd) |
| AR102767A1 (es) | 2014-12-05 | 2017-03-22 | Lilly Co Eli | Inhibidores de ezh2 |
| WO2016102493A1 (en) * | 2014-12-22 | 2016-06-30 | Bayer Pharma Aktiengesellschaft | Imidazopyridine ezh2 inhibitors |
| WO2016101956A2 (en) | 2014-12-23 | 2016-06-30 | University Of Copenhagen | Treatment of cancer by inhibiting ezh2 activity |
| US10961532B2 (en) | 2015-04-07 | 2021-03-30 | The General Hospital Corporation | Methods for reactivating genes on the inactive X chromosome |
| US20180221362A1 (en) * | 2015-08-03 | 2018-08-09 | Constellation Pharmaceuticals, Inc. | Ezh2 inhibitors and modulation of regulatory t-cell function |
| WO2017035234A1 (en) | 2015-08-24 | 2017-03-02 | Epizyme, Inc. | Method for treating cancer |
| TW201718598A (zh) | 2015-08-27 | 2017-06-01 | 美國禮來大藥廠 | Ｅｚｈ２抑制劑 |
| US10577350B2 (en) | 2015-08-28 | 2020-03-03 | Constellation Pharmaceuticals, Inc. | Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide |
| RS59763B1 (sr) * | 2015-11-19 | 2020-02-28 | Jiangsu Hengrui Medicine Co | Derivati benzofurana, postupci njihove pripreme i njihova upotreba u medicini |
| WO2017096233A1 (en) | 2015-12-04 | 2017-06-08 | Massachusetts Eye And Ear Infirmary | Treatment of hearing loss by inhibition of casein kinase 1 |
| CN109219439B (zh) | 2016-01-29 | 2022-09-20 | 马萨诸塞眼科耳科诊所 | 内耳支持细胞的扩增和分化及其使用方法 |
| WO2017139455A1 (en) | 2016-02-10 | 2017-08-17 | Wake Forest University Health Sciences | Model system of liver fibrosis and method of making and using the same |
| AU2017252460B2 (en) | 2016-04-22 | 2021-11-18 | Dana-Farber Cancer Institute, Inc. | EZH2 inhibitors and uses thereof |
| US10987353B2 (en) | 2016-05-04 | 2021-04-27 | The Wistar Institute Of Anatomy And Biology | Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs |
| US10457640B2 (en) | 2016-10-19 | 2019-10-29 | Constellation Pharmaceuticals, Inc. | Synthesis of inhibitors of EZH2 |
| MX386586B (es) | 2017-05-18 | 2025-03-19 | Jiangsu Hengrui Medicine Co | Cristal de base libre de derivados benzofurano y método de preparación. |
| KR20200088386A (ko) | 2017-11-14 | 2020-07-22 | 화이자 인코포레이티드 | Ezh2 억제제 병용 요법 |
| CA3104209A1 (en) | 2018-07-09 | 2020-01-16 | Fondation Asile Des Aveugles | Inhibition of prc2 subunits to treat eye disorders |
| CR20210281A (es) | 2018-10-30 | 2021-10-25 | Repare Therapeutics Inc | Compuestos, composiciones farmacéuticas y métodos de preparación de compuestos y de uso como inhibidores de la cinasa atr |
| CN113631541B (zh) | 2019-03-25 | 2024-10-01 | 上海华汇拓医药科技有限公司 | 酰胺类化合物制备方法及其在医药领域的应用 |
| WO2020216898A1 (en) | 2019-04-24 | 2020-10-29 | Institut Curie | Biomarkers for predicting resistance to cancer drugs |
| MX2022000854A (es) * | 2019-07-22 | 2022-02-10 | Repare Therapeutics Inc | Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr. |
| WO2021021986A1 (en) | 2019-07-31 | 2021-02-04 | Ribon Therapeutics, Inc. | Heterobicyclic amides as inhibitors of cd38 |
| JP2022545467A (ja) | 2019-08-22 | 2022-10-27 | ジュノー セラピューティクス インコーポレイテッド | Ｔ細胞療法とｚｅｓｔｅホモログ２エンハンサー（ＥＺＨ２）阻害剤との併用療法および関連方法 |
| JP7564888B2 (ja) * | 2020-05-01 | 2024-10-09 | ギリアード サイエンシーズ， インコーポレイテッド | Ｃｄ７３阻害性２，４－ジオキソピリミジン化合物 |
| CN114315839B (zh) * | 2020-09-30 | 2025-09-26 | 武汉人福创新药物研发中心有限公司 | 嘧啶二酮类化合物及其用途 |
| CN113292489B (zh) * | 2021-06-16 | 2022-08-30 | 泓博智源(开原)药业有限公司 | 二氯代二烷基烟腈的制备方法 |
| EP4422756A1 (en) | 2021-10-29 | 2024-09-04 | Gilead Sciences, Inc. | Cd73 compounds |
| WO2023244918A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | Quinolone bcl6 bifunctional degraders |
| EP4536658A1 (en) | 2022-06-13 | 2025-04-16 | Treeline Biosciences, Inc. | 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2889526B1 (fr) * | 2005-08-04 | 2012-02-17 | Aventis Pharma Sa | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
| CA2651072A1 (en) * | 2006-05-01 | 2007-11-08 | Pfizer Products Inc. | Substituted 2-amino-fused heterocyclic compounds |
| US20090012031A1 (en) * | 2007-07-03 | 2009-01-08 | The Regents Of The University Of Michigan | EZH2 Cancer Markers |
| CA2722923C (en) * | 2008-04-29 | 2016-08-02 | Boehringer Ingelheim International Gmbh | Indazole compounds as ccr1 receptor antagonists |
| US20100113415A1 (en) | 2008-05-29 | 2010-05-06 | Rajapakse Hemaka A | Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
| ES2951688T3 (es) | 2011-02-28 | 2023-10-24 | Epizyme Inc | Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos |
-
2011
- 2011-05-05 JP JP2013509262A patent/JP5889875B2/ja not_active Expired - Fee Related
- 2011-05-05 US US13/696,601 patent/US8637509B2/en not_active Expired - Fee Related
- 2011-05-05 WO PCT/US2011/035344 patent/WO2012005805A1/en not_active Ceased
- 2011-05-05 ES ES11803965.0T patent/ES2528269T3/es active Active
- 2011-05-05 EP EP11803965.0A patent/EP2566479B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527173A5 (https=) | ||
| JP2013528591A5 (https=) | ||
| JP2013544840A5 (https=) | ||
| JP2013525498A5 (https=) | ||
| CA2798622A1 (en) | Indoles | |
| AU2006200437B2 (en) | Substituted alkylamine derivatives and methods of use | |
| AU2003252011B2 (en) | Substituted 2-alkylamine nicotinic amide derivatives and use there of | |
| KR101439823B1 (ko) | 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제 | |
| AU2016358242B2 (en) | N-substituted indole derivatives as PGE2 receptor modulators | |
| JP2018118992A5 (https=) | ||
| TW200413330A (en) | Compounds for the treatment of abnormal cell growth | |
| BR112020003254A2 (pt) | moduladores da piruvato quinase e uso destes | |
| HRP20220096T1 (hr) | Inhibitori lizin specifične demetilaze-1 | |
| HRP20180546T1 (hr) | Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti | |
| JP2014531465A5 (https=) | ||
| JP2020526556A5 (https=) | ||
| JP2015508828A5 (https=) | ||
| ME02416B (me) | Trpv4 antagonisтi | |
| JP2016500073A5 (https=) | ||
| AU2002248340A1 (en) | Substituted alkylamine derivatives and methods of use | |
| BRPI0721137A2 (pt) | Compostos para modulação de atividade de c-fms e/ou c-kit e usos para os mesmos. | |
| JP2015526452A5 (https=) | ||
| TW200536851A (en) | Compounds and methods of use | |
| JP2015501784A5 (https=) | ||
| RU2009138137A (ru) | Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли |